Observational analysis reveals S. epidermidis influence on biofilm formation and immune responses in humans, suggesting its potential in probiotics.
Staphylococcus epidermidis , a ubiquitous inhabitant of human skin, has been known for decades for its capacity to form biofilm-associated infections on indwelling medical devices and has developed into a leading bacterium used in biofilm research. Early investigation on the biofilm matrix focused on S. epidermidis “slime,” and currently, S. epidermidis represents one of the most prevalent organisms for in-vivo biofilm infection models. More recently, S. epidermidis has also become a standard for the investigation of host-commensal interactions on human skin, especially the immune response to colonization that is often called “commensal immunity.” Finally, there are recent efforts to use S. epidermidis as a topically applied vehicle for probiotic pathogen exclusion efforts as well as anti-cancer and vaccination strategies.
No takes yet. Share an insight, caveat, or question.
Cheung et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: